Dublin, Oct. 11, 2018 (GLOBE NEWSWIRE) -- The "Global Schizophrenia Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering.

Global Schizophrenia Market and Competitive Landscape - 2018, provides comprehensive insights into Schizophrenia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Schizophrenia market size and drug sales. This research also provides insights into Schizophrenia epidemiology and late stage pipeline.

The research is classified into following sections - Schizophrenia overview with definitions, symptoms, etiology, diagnosis, treatment options; Schizophrenia pipeline insights covering late stage clinical trials pipeline; Schizophrenia prevalence trends by countries; Schizophrenia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.

Research Scope:

  • Schizophrenia pipeline: Find out the drugs in clinical trials for Schizophrenia by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Schizophrenia epidemiology: Find out the prevalence of Schizophrenia by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2023
  • Schizophrenia products: Identify key products marketed and prescribed for Schizophrenia by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Schizophrenia market size: Find out the market size for Schizophrenia drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2014
  • Schizophrenia drug sales: Find out the sales of Schizophrenia drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Schizophrenia drugs sales forecast: Sales forecast for Schizophrenia drugs to 2023 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Schizophrenia market share analysis: Find out the market shares of Schizophrenia drugs and outlook by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan

For more information about this report visit https://www.researchandmarkets.com/research/73qsgk/global?w=12

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Schizophrenia Drugs